Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.038x

Shanghai Fosun Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.40 Billion ≈ $350.75 Million USD) by net assets (CN¥62.49 Billion ≈ $9.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)

Cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Shanghai Fosun Pharmaceutical Group Co L stock price today for real-time trading data and today's change.

Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Shanghai Fosun Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see 600196 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Andritz AG VI:ANDR	0.044x
Smith AO Corporation NYSE:AOS	0.138x
Pepco Group B.V. WAR:PCO	0.674x
Alchip Technologies Ltd TW:3661	-0.063x
Verona Pharma PLC ADR NASDAQ:VRNA	0.110x
BARRY CALLEBA. ADR 1/100 F:BCLM	N/A
Eldorado Gold Corp TO:ELD	0.032x
Lottomatica Group SpA NYSE:LOTMY	0.362x

Annual Cash Flow Conversion Efficiency for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. Review 600196 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥62.49 Billion ≈ $9.14 Billion	CN¥6.01 Billion ≈ $878.76 Million	0.096x	+28.64%
2024-12-31	CN¥59.93 Billion ≈ $8.77 Billion	CN¥4.48 Billion ≈ $655.12 Million	0.075x	-3.07%
2023-12-31	CN¥56.62 Billion ≈ $8.28 Billion	CN¥4.36 Billion ≈ $638.48 Million	0.077x	-1.13%
2022-12-31	CN¥54.11 Billion ≈ $7.92 Billion	CN¥4.22 Billion ≈ $617.16 Million	0.078x	-4.51%
2021-12-31	CN¥48.38 Billion ≈ $7.08 Billion	CN¥3.95 Billion ≈ $577.83 Million	0.082x	+45.50%
2020-12-31	CN¥45.98 Billion ≈ $6.73 Billion	CN¥2.58 Billion ≈ $377.50 Million	0.056x	-31.75%
2019-12-31	CN¥39.20 Billion ≈ $5.74 Billion	CN¥3.22 Billion ≈ $471.54 Million	0.082x	-6.40%
2018-12-31	CN¥33.59 Billion ≈ $4.92 Billion	CN¥2.95 Billion ≈ $431.69 Million	0.088x	+1.23%
2017-12-31	CN¥29.74 Billion ≈ $4.35 Billion	CN¥2.58 Billion ≈ $377.57 Million	0.087x	+3.82%
2016-12-31	CN¥25.25 Billion ≈ $3.69 Billion	CN¥2.11 Billion ≈ $308.77 Million	0.084x	+6.55%
2015-12-31	CN¥20.67 Billion ≈ $3.02 Billion	CN¥1.62 Billion ≈ $237.21 Million	0.078x	+24.82%
2014-12-31	CN¥19.10 Billion ≈ $2.80 Billion	CN¥1.20 Billion ≈ $175.63 Million	0.063x	+9.71%
2013-12-31	CN¥17.66 Billion ≈ $2.58 Billion	CN¥1.01 Billion ≈ $148.03 Million	0.057x	+31.70%
2012-12-31	CN¥15.30 Billion ≈ $2.24 Billion	CN¥665.52 Million ≈ $97.39 Million	0.043x	+56.15%
2011-12-31	CN¥11.37 Billion ≈ $1.66 Billion	CN¥316.65 Million ≈ $46.34 Million	0.028x	+28.63%
2010-12-31	CN¥9.39 Billion ≈ $1.37 Billion	CN¥203.36 Million ≈ $29.76 Million	0.022x	-42.52%
2009-12-31	CN¥6.95 Billion ≈ $1.02 Billion	CN¥261.87 Million ≈ $38.32 Million	0.038x	-28.14%
2008-12-31	CN¥4.45 Billion ≈ $650.58 Million	CN¥233.04 Million ≈ $34.10 Million	0.052x	+72.08%
2007-12-31	CN¥4.32 Billion ≈ $631.62 Million	CN¥131.48 Million ≈ $19.24 Million	0.030x	-39.90%
2006-12-31	CN¥3.65 Billion ≈ $533.90 Million	CN¥184.91 Million ≈ $27.06 Million	0.051x	-22.64%
2005-12-31	CN¥2.88 Billion ≈ $420.71 Million	CN¥188.35 Million ≈ $27.56 Million	0.066x	-10.12%
2004-12-31	CN¥2.81 Billion ≈ $411.75 Million	CN¥205.10 Million ≈ $30.01 Million	0.073x	-2.08%
2003-12-31	CN¥2.02 Billion ≈ $295.14 Million	CN¥150.14 Million ≈ $21.97 Million	0.074x	+21.56%
2002-12-31	CN¥1.67 Billion ≈ $244.87 Million	CN¥102.47 Million ≈ $15.00 Million	0.061x	+18.84%
2001-12-31	CN¥1.32 Billion ≈ $193.54 Million	CN¥68.15 Million ≈ $9.97 Million	0.052x	-54.64%
2000-12-31	CN¥1.22 Billion ≈ $178.30 Million	CN¥138.43 Million ≈ $20.26 Million	0.114x	+95.42%
1999-12-31	CN¥657.08 Million ≈ $96.15 Million	CN¥38.20 Million ≈ $5.59 Million	0.058x	-53.64%
1998-12-31	CN¥530.77 Million ≈ $77.67 Million	CN¥66.55 Million ≈ $9.74 Million	0.125x	--

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic

Market Cap

$7.31 Billion

CN¥49.95 Billion CNY

Market Cap Rank

#2701 Global

#293 in China

Share Price

CN¥23.58

Change (1 day)

-0.34%

52-Week Range

CN¥21.21 - CN¥28.88

All Time High

CN¥85.06